Back to other trials
Vaccine
COVID-19
The global outbreak of COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to a significant public health crisis, impacting communities and economies worldwide. The urgent need for an effective preventive measure has spurred the rapid development of COVID-19 vaccine candidates. Clinical trials play a pivotal role in assessing the safety, efficacy, and potential impact of these vaccines on reducing the spread of the virus.
COVID-19 Vaccine
ACRA is looking for participants who:
• between the ages of 50-65
• who are not high risk of severe COVID-19 due to underlying medical conditions or risk factors that demonstrated a conclusive increase in risk for at least one severe COVID-19 outcome, as described by the Centers for Disease Control and Prevention (CDC)
• between the ages of 50-65
• who are not high risk of severe COVID-19 due to underlying medical conditions or risk factors that demonstrated a conclusive increase in risk for at least one severe COVID-19 outcome, as described by the Centers for Disease Control and Prevention (CDC)
Compensation
up to $450
Age
50 to < 65
Duration
6 months
Visits
4